What is Mounjaro (tirzepatide) used for?
Mounjaro® is an FDA-approved medication used to treat type 2 diabetes. It is a dual GLP-1/GIP* receptor agonist which acts to stimulate the release of insulin by the pancreas which lowers blood sugar levels. It can also improve insulin sensitivity and promote weight loss. Mounjaro is not FDA-approved for weight loss, but a medication called Zepbound®, containing the same active ingredient tirzepatide, was recently approved for weight loss treatment. In clinical trials, individuals who took tirzepatide for up to a year and a half, lost an average of 26.6% of their body weight. Doctors may prescribe Mounjaro to patients without diabetes (considered off-label use) for the purpose of weight loss in combination with healthy nutrition and increased physical activity so long as it is medically appropriate.
Keep in mind that coverage and costs vary based on your specific insurance plan. To learn more about your exact costs for Mounjaro or other medications, contact your insurance company using the phone number on the back of your insurance card.
Some people choose to get compounded semaglutide medication instead of the brand name medication like Mounjaro. Although they are often available at a lower cost, it’s important to know that these compounded weight loss medications come with real risks. The molecule has not been tested in clinical trials and approved by the FDA for safety and efficacy. Additionally, compounding facilities may not be FDA monitored and there is a risk of contaminants and patient dosing errors. Form is dedicated to providing quality evidence-based medical weight loss care. The National Obesity Medicine Association recently published an extensive position statement advising against using compounded peptides that also highlights the risk to individuals. Form Health is aligned with the Obesity Medicine Association’s position. We do not prescribe compounded medication.
*glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP)
.png)
Lauren Lemieux, MD, FACP, DABOM
Dr. Lauren Lemieux completed her Internal Medicine residency and fellowship in Clinical Nutrition at UCLA. She is board certified in Internal Medicine and diplomate of the American Board of Obesity Medicine, and as a Physician Nutrition Specialist. She is also a fellow of the American College of Physicians. Dr. Lemieux is passionate about helping her patients reach their health goals using personalized nutrition, lifestyle and weight management strategies.
